openPR Logo
Press release

Future of Global Postmenopausal Osteoporosis Therapeutics Market : 2015 - 2021

01-05-2017 03:07 PM CET | Health & Medicine

Press release from: Persistence Market Research Pvt. Ltd

Future of Global Postmenopausal Osteoporosis Therapeutics

Osteoporosis is an orthopedic condition where the bone density and bone mass decreases and eventually increases the risk of bone fracture. Osteoporosis is one of the most common age related diseases worldwide and also represents a major public health problem. Osteoporosis is common among females than in the male population. Women with age more than 50 years are more prone to osteoporosis due to hormonal changes occurring after menopause. The currently available technologies fail to cure postmenopausal osteoporosis completely and thus healthcare professionals prefer medicinal therapy for treatment of postmenopausal osteoporosis.

A Sample of this Report is Available Upon Request @ http://www.persistencemarketresearch.com/samples/5882

Considering the relation of age in postmenopausal osteoporosis, aging of population worldwide is the major factor that is increasing the morbidity rate of postmenopausal osteoporosis. Increasing prevalence of this condition and innovations in the corresponding drug market are major driving forces of the postmenopausal osteoporosis therapeutics market. While high standards for approval of any new product to launch into the market, competition from the emerging alternative technologies and intense competition from generics are restraining growth of this market. Mergers and acquisitions taking place in the market is one of the major restraining force of postmenopausal osteoporosis therapeutics market.

To View TOC of this Report is Available Upon Request @ http://www.persistencemarketresearch.com/toc/5882

Currently, North America dominates the postmenopausal osteoporosis therapeutics market and is closely followed by Europe. Asia-Pacific is a lucrative regional market for such drugs considering factors such as increasing healthcare spending and improving healthcare infrastructure. Gradual; development of the medical tourism industry in the region is also expected to further spur the growth of postmenopausal osteoporosis therapeutics market in Asia-Pacific. Some of the major companies contributing to the global postmenopausal osteoporosis therapeutics market are Eli Lilly, Pfizer, Inc., F. Hoffman La Roche, Procter & Gamble and Merck.

About Us
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated re-search, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Con-sumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s en-gagement models are highly flexible without compromising on its deep-seated research values.

Contact
Persistence Market Research Pvt. Ltd
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Future of Global Postmenopausal Osteoporosis Therapeutics Market : 2015 - 2021 here

News-ID: 406359 • Views:

More Releases from Persistence Market Research Pvt. Ltd

Innovative Rehabilitation Technologies Drive Growth in Stroke Rehabilitation Market to Hit Surpass US$ 679.6 Million by 2032
Innovative Rehabilitation Technologies Drive Growth in Stroke Rehabilitation Mar …
Stroke Rehabilitation Market Size The global stroke rehabilitation market size was valued at US$ 266.4 million in 2021 and is expected to grow at a CAGR of 9% from 2022 to 2032. Revenue generated from the sales of stroke rehabilitation solutions will surge to US$ 679.6 Million by the end of 2032. The growth of the market is being driven by the increasing incidence of strokes, the growing demand for innovative rehabilitation
Launch of New Laser-Based Devices by Key Players Fueling Growth of Global Aesthetic Lasers Market
Launch of New Laser-Based Devices by Key Players Fueling Growth of Global Aesthe …
Market Study on Aesthetic Lasers The aesthetic lasers market reached US$2.8 billion in global revenue in 2021, and it will continue to expand quickly, with a value CAGR of 6.4%, to reach US$5.5 billion by the end of 2032. The growth of the market is being driven by the increasing demand for minimally invasive cosmetic procedures, rising disposable income, technological advancements, and growing medical tourism. Stay Ahead with Market Intelligence Get Free
Predictive Insights for Precision Medicine: The Global Biosimulation Market is Set to Hit USD 10 billion by 2030
Predictive Insights for Precision Medicine: The Global Biosimulation Market is S …
Biosimulation Market Research The Global Biosimulation Market Size was valued at USD 2.9 billion in 2022 and is expected to reach USD 10.0 billion by 2030, registering a CAGR of 16.9% during the forecast period. The growth of the biosimulation market is being driven by the increasing use of biosimulation in a variety of applications, such as drug discovery, clinical trials, and toxicity prediction.  Market Overview The biosimulation market has experienced rapid growth
Wheelchair and Components Market: Growing Demand for Lightweight and Smart Wheelchairs to Boost Growth
Wheelchair and Components Market: Growing Demand for Lightweight and Smart Wheel …
Wheelchair and Components Market The global wheelchair and components market is projected to reach USD 17.9 billion by 2033, at a CAGR of 3.7% from 2022-2033. The growth of the market is driven by the increasing prevalence of disabilities, the rising geriatric population, and technological advancements in wheelchair design and manufacturing. Click Here to Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/12961 The global wheelchair and components market has witnessed significant growth in

All 5 Releases


More Releases for Osteoporosis

Rising Prevalence Of Osteoporosis Fuels Growth In The Osteoporosis Drug Market: …
The Osteoporosis Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Osteoporosis Drugs Market Size During the Forecast Period? The market for medications for osteoporosis has seen a consistent rise in recent years. The current market value of $12.33 billion in 2024
Rising Prevalence Of Osteoporosis Spurs Momentum In Postmenopausal Osteoporosis …
The Postmenopausal Osteoporosis Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Current Postmenopausal Osteoporosis Treatment Market Size and Its Estimated Growth Rate? The market for treatment of postmenopausal osteoporosis has seen a steady increase in size over the recent years. It's projected
Osteoporosis Drug Market, By Type (Primary Osteoporosis and Secondary Osteoporos …
Osteoporosis is a condition of bone weakening or bones becomes fragile and likely to break. In other words, osteoporosis is a condition wherein the bone density decreases. This is specially witnessed in old age people. Osteoporosis brings along back pain, stooped posture, bone fracture and tooth loss. View Detailed Report" https://www.databridgemarketresearch.com/reports/global-osteoporosis-drug-market The global osteoporosis drug market is experiencing steady growth driven by factors such as the increasing aging population, rising prevalence of
Osteoporosis Drugs: The Complete Review
Medication for osteoporosis increases bone mineral density and reduces fracture risk. Some osteoporosis medications promote bone growth while others reduce bone loss. The bones may begin to deteriorate as age more quickly than the body can heal them. The doctor could determine that people have osteoporosis if they have significant bone density loss. To receive free sample pages of this report@ https://www.psmarketresearch.com/market-analysis/osteoporosis-drugs-market/report-sample Although osteoporosis cannot be treated, it can be slowed down or
Osteoporosis Drugs Market: Demand for Osteoporosis Drugs High Among Geriatric Po …
The global osteoporosis drugs market is analyzed in a report by Transparency Market Research (TMR). The market is expected to grow due to the increasing geriatric population across the globe. The market for osteoporosis drugs is considered semi-consolidated as a handful of players hold a larger share in the market. As per the analysis, Novartis International AG, Eli Lilly and Company, Merck & Co. Inc., Pfizer Inc., and Amgen Inc.
Global Postmenopausal Osteoporosis Therapeutics Market
The Postmenopausal Osteoporosis Therapeutics Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Osteoporosis is an orthopedic condition where the bone density and bone mass decreases and eventually increases the risk of bone fracture. Osteoporosis is one of the most common age related